| CERALASERTIB | Small molecule | breast carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | metastatic colorectal cancer | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | prostate cancer | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | breast neoplasm | Serine-protein kinase ATR inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | Fallopian Tube Carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | oral squamous cell carcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | metastatic prostate cancer | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | non-small cell lung carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | non-small cell lung carcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ELIMUSERTIB | Small molecule | ovarian cancer | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | head and neck squamous cell carcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Completed | ClinicalTrials |
| CERALASERTIB | Small molecule | carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | small cell lung carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | small cell lung carcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| ELIMUSERTIB | Small molecule | Mantle cell lymphoma | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | cancer | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | melanoma | Serine-protein kinase ATR inhibitor | 2.0 | Recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | breast cancer | Serine-protein kinase ATR inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | ureter urothelial carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| M4344 | Small molecule | ovarian cancer | Serine-protein kinase ATR inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | neoplasm | Serine-protein kinase ATR inhibitor | 2.0 | Recruiting | ClinicalTrials |
| M4344 | Small molecule | neoplasm | Serine-protein kinase ATR inhibitor | 1.0 | Completed | ClinicalTrials |
| CERALASERTIB | Small molecule | bile duct cancer | Serine-protein kinase ATR inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | neoplasm | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | small cell lung carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | squamous cell carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | breast cancer | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| M4344 | Small molecule | breast cancer | Serine-protein kinase ATR inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| BERZOSERTIB | Small molecule | bladder transitional cell carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | breast cancer | Serine-protein kinase ATR inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | osteosarcoma | Serine-protein kinase ATR inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | ovarian neoplasm | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | hypopharyngeal squamous cell carcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | neoplasm | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | cancer | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | metastatic malignant neoplasm | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | non-small cell lung carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | colorectal adenocarcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | small cell lung carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | pancreatic carcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | cancer | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | neoplasm | Serine-protein kinase ATR inhibitor | 1.0 | Completed | ClinicalTrials |
| ELIMUSERTIB | Small molecule | metastatic malignant neoplasm | Serine-protein kinase ATR inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| CERALASERTIB | Small molecule | ovarian cancer | Serine-protein kinase ATR inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| BERZOSERTIB | Small molecule | laryngeal squamous cell carcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | oropharynx squamous cell carcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | primary peritoneal carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | adenocarcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | chronic lymphocytic leukemia | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | breast carcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | prolymphocytic leukemia | Serine-protein kinase ATR inhibitor | 1.0 | Completed | ClinicalTrials |
| BERZOSERTIB | Small molecule | small cell lung carcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | ovarian carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | neoplasm | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | cancer | Serine-protein kinase ATR inhibitor | 1.0 | Completed | ClinicalTrials |
| BERZOSERTIB | Small molecule | ovarian cancer | Serine-protein kinase ATR inhibitor | 1.0 | Completed | ClinicalTrials |
| CERALASERTIB | Small molecule | small cell lung carcinoma | Serine-protein kinase ATR inhibitor | 2.0 | Completed | ClinicalTrials |
| BERZOSERTIB | Small molecule | leiomyosarcoma | Serine-protein kinase ATR inhibitor | 2.0 | Recruiting | ClinicalTrials |
| BERZOSERTIB | Small molecule | cervical adenocarcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | neoplasm | Serine-protein kinase ATR inhibitor | 1.0 | Unknown status | ClinicalTrials |
| CERALASERTIB | Small molecule | chronic lymphocytic leukemia | Serine-protein kinase ATR inhibitor | 1.0 | Completed | ClinicalTrials |
| BERZOSERTIB | Small molecule | non-small cell lung carcinoma | Serine-protein kinase ATR inhibitor | 1.0 | Recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | non-small cell lung carcinoma | Serine-protein kinase ATR inhibitor | 3.0 | Recruiting | ClinicalTrials |
| ELIMUSERTIB | Small molecule | neoplasm | Serine-protein kinase ATR inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| CERALASERTIB | Small molecule | diffuse large B-cell lymphoma | Serine-protein kinase ATR inhibitor | 1.0 | Completed | ClinicalTrials |